In addition, HMOX1 gene promoter polymorphism affects the expression of HO-1 in humans, suggesting an additional indication for the clinical relevance of studies on the role of HO-1 in AAA pathophysiology [5]. The gene discussed is HMOX1; the disease is triple-A syndrome.